{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T08:30:07Z","timestamp":1788856207912,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1801304\\u20138"],"award-info":[{"award-number":["2023YFD1801304\\u20138"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijbiomac.2025.147995","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:01:53Z","timestamp":1759158113000},"page":"147995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"P3","title":["Targeting gut microbiota in non-alcoholic fatty liver disease (NAFLD): Pathogenesis and therapeutic insights: A review"],"prefix":"10.1016","volume":"330","author":[{"given":"Shuhao","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudassar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tariq","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal Ayub","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiju","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.147995_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0010","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the american heart association, arterioscler","volume":"42","author":"Duell","year":"2022","journal-title":"Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0015","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.997018","article-title":"Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications","volume":"12","author":"Fang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0025","first-page":"414","article-title":"Characteristics and dynamic changes of gut microbiota in cats with colitis","volume":"44","author":"Xie","year":"2024","journal-title":"Pak. Vet. J."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0030","first-page":"449","article-title":"Comparative analysis of the gut microbiota between two horse species","volume":"44","author":"Wang","year":"2024","journal-title":"Pak. Vet. J."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0035","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2223339","article-title":"Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-plus trial sub analysis","volume":"15","author":"G\u00f3mez-P\u00e9rez","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1500453","article-title":"Gut microbiome and NAFLD: impact and therapeutic potential","volume":"15","author":"Li","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09637486.2024.2435849","article-title":"Ellagic acid alleviates high-fructose diet-induced non-alcoholic fatty liver disease by modulating liver metabolic profiles and gut microbiota","volume":"76","author":"Luo","year":"2025","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0050","article-title":"Targeting non-alcoholic fatty liver disease with hawthorn ethanol extract (HEE): a comprehensive examination of hepatic lipid reduction and gut microbiota modulation","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0055","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1111\/jgh.16256","article-title":"Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"38","author":"Rong","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1110536","article-title":"Gut microbiota modulation in patients with non-alcoholic fatty liver disease: effects of current treatments and future strategies","volume":"10","author":"Maestri","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0065","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-3-031-63657-8_18","article-title":"Nonalcoholic fatty liver disease and staging of hepatic fibrosis","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0070","article-title":"Prevalence and risk factor analysis for the nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Polyzos, epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0085","article-title":"Dietary fructose: a literature review of current evidence and implications on metabolic health","volume":"16","author":"Agarwal","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155005","article-title":"Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis","volume":"119","author":"Yin","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0100","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.chom.2022.05.002","article-title":"Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids","volume":"30","author":"Le","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0110","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4093\/dmj.2020.0039","article-title":"Distinct dose-dependent association of free fatty acids with diabetes development in nonalcoholic fatty liver disease patients","volume":"45","author":"Li","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-biochem-070820-125228","article-title":"Short- and long-term adaptation to altered levels of glucose: fifty years of scientific adventure","volume":"90","author":"Uyeda","year":"2021","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0120","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.molmet.2017.07.006","article-title":"Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice","volume":"6","author":"Jois","year":"2017","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0130","article-title":"Gut microbiota dysbiosis amplifies thiram hepatotoxicity via a mitochondrial-autophagy-apoptosis nexus orchestrated by the gut-liver axis","volume":"112104","author":"Hou","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0140","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0145","article-title":"Multiomics analysis reveals the impact of microbiota on host metabolism in hepatic steatosis","volume":"9","author":"Zeybel","year":"2022","journal-title":"Adv. Sci. (Weinheim, Ger.)"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1528258","article-title":"Characterization of the hepatic flora and metabolome in nonalcoholic fatty liver disease","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.cmet.2019.08.002","article-title":"Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease","volume":"30","author":"Loomba","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0160","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hep.31417","article-title":"Microbiomics, metabolomics, predicted metagenomics, and hepatic steatosis in a population-based study of 1,355 adults","volume":"73","author":"Alferink","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0165","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1038\/s41598-020-65051-8","article-title":"Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"10","author":"Pan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0170","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCRESAHA.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0175","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2018.12.149","article-title":"Liraglutide protects against inflammatory stress in non-alcoholic fatty liver by modulating Kupffer cells M2 polarization via cAMP-PKA-STAT3 signaling pathway","volume":"510","author":"Li","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0180","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12935-020-01354-0","article-title":"LncRNA FTX represses the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via regulating the M1\/M2 polarization of Kupffer cells","volume":"20","author":"Wu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0195","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41598-017-01751-y","article-title":"Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0200","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.cmet.2023.08.002","article-title":"Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations","volume":"35","author":"Ni","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0205","article-title":"Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119160","article-title":"Jingfang granules alleviates the lipid peroxidation induced ferroptosis in rheumatoid arthritis rats by regulating gut microbiota and metabolism of short chain fatty acids","volume":"339","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.379","article-title":"4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-\u03b1","volume":"11","author":"Chen","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0220","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.jcmgh.2021.05.006","article-title":"Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene","volume":"12","author":"Zhao","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0225","doi-asserted-by":"crossref","DOI":"10.1177\/11786469211070533","article-title":"Intestinal dysbiosis, the tryptophan pathway and nonalcoholic steatohepatitis","volume":"15","author":"Chen","year":"2022","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00726-022-03123-x","article-title":"Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function","volume":"54","author":"Hyland","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.567654","article-title":"Microbial metabolites: critical regulators in NAFLD","volume":"11","author":"Dai","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0245","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.celrep.2019.08.080","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"28","author":"Krishnan","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092062","article-title":"Indole-3-acetic acid alleviates nonalcoholic fatty liver disease in mice via attenuation of hepatic lipogenesis, and oxidative and inflammatory stress","volume":"11","author":"Ji","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0255","first-page":"1","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0260","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0265","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.chom.2020.01.021","article-title":"Dysbiosis-induced secondary bile acid deficiency promotes intestinal inflammation","volume":"27","author":"Sinha","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0275","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/164_2019_238","article-title":"The pharmacology of bile acids and their receptors","volume":"256","author":"Fiorucci","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0285","doi-asserted-by":"crossref","first-page":"E346","DOI":"10.1152\/ajpendo.00485.2015","article-title":"Bile acids induce uncoupling protein 1-dependent thermogenesis and stimulate energy expenditure at thermoneutrality in mice","volume":"310","author":"Zietak","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0290","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/db18-0315","article-title":"TGR5 activation promotes stimulus-secretion coupling of pancreatic \u03b2-cells via a PKA-dependent pathway","volume":"68","author":"Maczewsky","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0295","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1038\/s41467-020-18262-6","article-title":"Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/nu16193384","article-title":"A sustained-release butyrate tablet suppresses ex vivo t helper cell activation of osteoarthritis patients in a double-blind placebo-controlled randomized trial","volume":"16","author":"Korsten","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136921","article-title":"Intestinal permeability is a mechanical rheostat in the pathogenesis of liver cirrhosis","volume":"22","author":"Nishimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0320","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0325","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1073\/pnas.1917597117","article-title":"Microbiota-derived butyrate dynamically regulates intestinal homeostasis through regulation of actin-associated protein synaptopodin","volume":"117","author":"Wang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0330","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3389\/fimmu.2019.02113","article-title":"Tryptophan dietary impacts gut barrier and metabolic diseases","volume":"10","author":"Taleb","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/nu15061355","article-title":"In vitro probiotic properties of Bifidobacterium animalis subsp. lactis SF and its alleviating effect on non-alcoholic fatty liver disease","volume":"15","author":"Lv","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0340","first-page":"1243","article-title":"Impact of Bacillus subtilis probiotic on growth performance, bone health, intestinal morphology, and cecal microbiota in cobb broiler chicks","volume":"44","author":"Yu","year":"2024","journal-title":"Pak. Vet. J."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0345","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2390176","article-title":"Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion","volume":"16","author":"Wu","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0350","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00018-017-2672-0","article-title":"Bifidobacteria and the infant gut: an example of co-evolution and natural selection","volume":"75","author":"Turroni","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0355","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2323\/jgam.2017.06.003","article-title":"Inhibitory effect of Lactococcus lactis on the bioactivity of periodontopathogens","volume":"64","author":"Shin","year":"2018","journal-title":"J. Gen. Appl. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0360","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1186\/s12876-024-03424-3","article-title":"The effect of probiotic supplementation on non-alcoholic fatty liver disease (NAFLD) fibrosis score in patients attending a tertiary hospital clinic in Cairo","volume":"24","author":"Abd El Hamid","year":"2024","journal-title":"Egypt, BMC Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0365","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12876-020-01194-2","article-title":"Fructo-oligosaccharides ameliorate steatohepatitis, visceral adiposity, and associated chronic inflammation via increased production of short-chain fatty acids in a mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Takai","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/nu12040937","article-title":"Randomised double-blind placebo-controlled trial of inulin with metronidazole in non-alcoholic fatty liver disease (NAFLD)","volume":"12","author":"Chong","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0375","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajcnut.2024.05.017","article-title":"Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism in patients with nonalcoholic simple fatty liver disease: a randomized controlled trial","volume":"120","author":"He","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/nu16111571","article-title":"Prebiotic treatment in patients with nonalcoholic fatty liver disease (NAFLD)-a randomized pilot trial","volume":"16","author":"Reshef","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109546","article-title":"The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiota","volume":"125","author":"Zhang","year":"2024","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0390","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.5114\/aoms.2019.86611","article-title":"Effect of Lactobacillus paracasei N1115 and fructooligosaccharides in nonalcoholic fatty liver disease","volume":"15","author":"Yao","year":"2019","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0395","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics alter fecal microbiomes, but not liver fat or fibrosis, in a randomized trial of patients with nonalcoholic fatty liver disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0400","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.14309\/ajg.0000000000000661","article-title":"Allogenic fecal microbiota transplantation in patients with nonalcoholic fatty liver disease improves abnormal small intestinal permeability: a randomized control trial","volume":"115","author":"Craven","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0405","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1136\/gutjnl-2019-318320","article-title":"Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time","volume":"69","author":"de Groot","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0410","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep4.1601","article-title":"Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis","volume":"4","author":"Witjes","year":"2020","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0415","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.2147\/DDDT.S243893","article-title":"Radix polygoni multiflori and its main component emodin attenuate non-alcoholic fatty liver disease in zebrafish by regulation of AMPK signaling pathway","volume":"14","author":"Yu","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116734","article-title":"Emodin-8-O-\u03b2-D-glucopyranoside alleviates cholestasis by maintaining intestinal homeostasis and regulating lipids and bile acids metabolism in mice","volume":"258","author":"Wu","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0425","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/1535370214530247","article-title":"Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides","volume":"239","author":"Jia","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115457","article-title":"Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis","volume":"296","author":"Ye","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154208","article-title":"The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-\u03baB\/CCL3\/CCR1 axis","volume":"103","author":"Tan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0440","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1039\/D4FO05847J","article-title":"Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial","volume":"16","author":"Tian","year":"2025","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115145","article-title":"Shenling Baizhu san ameliorates ulcerative colitis by regulating the gut microbiota and its tryptophan metabolites: a complementary medicine to mesalamine","volume":"291","author":"Jiao","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0450","article-title":"Shenling Baizhu san ameliorates non-alcoholic fatty liver disease in mice by modulating gut microbiota and metabolites","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0465","article-title":"The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial","volume":"13","author":"Hui","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jare.2023.01.008","article-title":"Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis","volume":"52","author":"Li","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0475","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12916-024-03317-y","article-title":"Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults","volume":"22","author":"Zeng","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0480","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.18632\/oncotarget.24066","article-title":"Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice","volume":"9","author":"Yamada","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0485","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Pars\u00e9us","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0490","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2304159","article-title":"Bacteroides thetaiotaomicron ameliorates mouse hepatic steatosis through regulating gut microbial composition, gut-liver folate and unsaturated fatty acids metabolism","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0495","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020640","article-title":"The effects of probiotics on small intestinal microbiota composition, inflammatory cytokines and intestinal permeability in patients with non-alcoholic fatty liver disease","volume":"11","author":"Ayob","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0500","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12876-021-01660-5","article-title":"A randomised placebo controlled trial of VSL#3(\u00ae) probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease","volume":"21","author":"Chong","year":"2021","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0505","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1007\/s00253-019-09703-4","article-title":"Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK\/Nrf2 pathway","volume":"103","author":"Zhao","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0510","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1099800420942942","article-title":"Oral probiotic Bifidobacterium longum supplementation improves metabolic parameters and alters the expression of the renin-angiotensin system in obese mice liver","volume":"23","author":"Machado","year":"2021","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0515","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165872","article-title":"Lactobacillus strains alleviated hyperlipidemia and liver steatosis in aging rats via activation of AMPK","volume":"21","author":"Lew","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0520","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/13880209.2021.1979594","article-title":"Jiang Zhi granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis","volume":"59","author":"Yu","year":"2021","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155712","article-title":"Shenling Baizhu powder alleviates non-alcoholic fatty liver disease by modulating autophagy and energy metabolism in high-fat diet-induced rats","volume":"130","author":"Pan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.147995_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118165","article-title":"Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways","volume":"329","author":"You","year":"2024","journal-title":"J. Ethnopharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025085526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025085526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:39:49Z","timestamp":1781743189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025085526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":106,"alternative-id":["S0141813025085526"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147995","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting gut microbiota in non-alcoholic fatty liver disease (NAFLD): Pathogenesis and therapeutic insights: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"147995"}}